Connor, Clark & Lunn Investment Management (CC&L)’s PMV Pharmaceuticals PMVP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-267,636
| Closed | -$292K | – | 1644 |
|
|
2025
Q1 | $292K | Sell |
267,636
-103,284
| -28% | -$113K | ﹤0.01% | 1255 |
|
|
2024
Q4 | $560K | Sell |
370,920
-70,104
| -16% | -$106K | ﹤0.01% | 1121 |
|
|
2024
Q3 | $657K | Buy |
441,024
+1,885
| +0.4% | +$2.81K | ﹤0.01% | 1019 |
|
|
2024
Q2 | $711K | Buy |
439,139
+5,286
| +1% | +$8.56K | ﹤0.01% | 945 |
|
|
2024
Q1 | $738K | Buy |
433,853
+248,730
| +134% | +$423K | ﹤0.01% | 980 |
|
|
2023
Q4 | $574K | Buy |
185,123
+15,424
| +9% | +$47.8K | ﹤0.01% | 1008 |
|
|
2023
Q3 | $1.04M | Buy |
169,699
+5,737
| +3% | +$35.2K | 0.01% | 806 |
|
|
2023
Q2 | $1.03M | Buy |
163,962
+7,904
| +5% | +$49.5K | 0.01% | 788 |
|
|
2023
Q1 | $744K | Buy |
156,058
+40,369
| +35% | +$193K | ﹤0.01% | 795 |
|
|
2022
Q4 | $1.01M | Buy |
+115,689
| New | +$1.01M | 0.01% | 703 |
|